User profiles for Vincent C. Tam
Vincent C. TamCenter for Infectious Disease Research Verified email at seattlebiomed.org Cited by 6255 |
Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
…, V Breder, A Vasilyev, A Heurgué, VC Tam… - NEJM …, 2022 - evidence.nejm.org
Background A single, high priming dose of tremelimumab (anti-cytotoxic T lymphocyte–associated
antigen 4) plus durvalumab (anti–programmed cell death ligand-1), an infusion …
antigen 4) plus durvalumab (anti–programmed cell death ligand-1), an infusion …
Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review
VC Tam, SR Knowles, PL Cornish, N Fine… - Cmaj, 2005 - Can Med Assoc
Background: Over a quarter of hospital prescribing errors are attributable to incomplete
medication histories being obtained at the time of admission. We undertook a systematic review …
medication histories being obtained at the time of admission. We undertook a systematic review …
Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000
…, DJ Schneider, VC Tam… - Proceedings of the …, 2002 - National Acad Sciences
The ability of Pseudomonas syringae pv. tomato DC3000 to be pathogenic on plants depends
on the Hrp (hypersensitive response and pathogenicity) type III protein secretion system …
on the Hrp (hypersensitive response and pathogenicity) type III protein secretion system …
[HTML][HTML] Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation
VC Tam, O Quehenberger, CM Oshansky, R Suen… - Cell, 2013 - cell.com
Bioactive lipid mediators play a crucial role in the induction and resolution of inflammation.
To elucidate their involvement during influenza infection, liquid chromatography/mass …
To elucidate their involvement during influenza infection, liquid chromatography/mass …
Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system
M Dziejman, D Serruto, VC Tam… - Proceedings of the …, 2005 - National Acad Sciences
Non-O1, non-O139 Vibrio cholerae can cause gastroenteritis and extraintestinal infections,
but, unlike O1 and O139 strains of V. cholerae, little is known about the virulence gene …
but, unlike O1 and O139 strains of V. cholerae, little is known about the virulence gene …
[HTML][HTML] A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization
VC Tam, D Serruto, M Dziejman, W Brieher… - Cell host & …, 2007 - cell.com
We have previously characterized a non-O1, non-O139 Vibrio cholerae strain, AM-19226,
that lacks the known virulence factors but contains components of a type III secretion system (…
that lacks the known virulence factors but contains components of a type III secretion system (…
The Pseudomonas syringae type III‐secreted protein HopPtoD2 possesses protein tyrosine phosphatase activity and suppresses programmed cell death in plants
The bacterial plant pathogen Pseudomonas syringae possesses a type III protein secretion
system that delivers many virulence proteins into plant cells. A subset of these proteins (…
system that delivers many virulence proteins into plant cells. A subset of these proteins (…
Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: phase 3 CALGB 80802 randomized …
…, R Goel, PE Lammers, TS Bekaii-Saab, VC Tam… - JAMA …, 2019 - jamanetwork.com
Importance Previous communication has reported significant improvement in overall survival
(OS) when using doxorubicin plus sorafenib in the treatment of advanced hepatocellular …
(OS) when using doxorubicin plus sorafenib in the treatment of advanced hepatocellular …
Serum alpha-fetoprotein levels and clinical outcomes in the phase III CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular …
Purpose: The phase III CELESTIAL study demonstrated improved overall survival (OS) and
progression-free survival (PFS) with cabozantinib versus placebo in patients with previously …
progression-free survival (PFS) with cabozantinib versus placebo in patients with previously …
Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections
VC Tam - Seminars in immunology, 2013 - Elsevier
Bioactive lipid mediators play crucial roles in promoting the induction and resolution of
inflammation. Eicosanoids and other related unsaturated fatty acids have long been known to …
inflammation. Eicosanoids and other related unsaturated fatty acids have long been known to …